Reagents and consumables
Ended Awarded
- Contract number
- 75N91022F00014
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,216
Award facts
- Contract value 100% obligated
- $20,215.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation was awarded a $20,215.65 firm fixed price delivery order contract by the National Institutes of Health's National Cancer Institute to provide reagents and consumables. The contract has no set-aside designation and runs through October 24, 2022. As the prime contractor, Roche Diagnostics will supply the requested products to support the National Cancer Institute's biomedical research efforts from its place of performance in Castleton, Indiana.
Quick answers
Who was awarded contract 75N91022F00014?
75N91022F00014 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on July 25, 2022.
How much is contract 75N91022F00014 worth?
The government has obligated $20,216 on 75N91022F00014.
Is contract 75N91022F00014 an order under another contract?
Yes. 75N91022F00014 is a delivery order under 75N91019D00038, an indefinite delivery contract.
Was contract 75N91022F00014 competed?
The extent of competition for 75N91022F00014 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award